{"id":"https://openalex.org/W4379985133","doi":"https://doi.org/10.1158/1538-7445.am2023-5454","title":"Abstract 5454: Peripheral blood biomarkers in Phase II study of pembrolizumab in combination with oral binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer","display_name":"Abstract 5454: Peripheral blood biomarkers in Phase II study of pembrolizumab in combination with oral binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4379985133","doi":"https://doi.org/10.1158/1538-7445.am2023-5454"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-5454","doi":"https://doi.org/10.1158/1538-7445.am2023-5454","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-5454","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052187738","display_name":"Saranya Chumsri","orcid":"https://orcid.org/0000-0001-7117-1446","observed_orcids":["https://orcid.org/0000-0001-7117-1446"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saranya Chumsri","raw_affiliation_strings":["1Mayo Clinic Florida, Jacksonville, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic Florida, Jacksonville, FL;","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076758389","display_name":"Joseph J. Larson","orcid":"https://orcid.org/0000-0001-8372-0465","observed_orcids":["https://orcid.org/0000-0001-8372-0465"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph J. Larson","raw_affiliation_strings":["2Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005317276","display_name":"Daniel L. Adams","orcid":"https://orcid.org/0000-0002-1916-9637","observed_orcids":["https://orcid.org/0000-0002-1916-9637"]},"institutions":[{"id":"https://openalex.org/I4210118300","display_name":"Creatv MicroTech (United States)","ror":"https://ror.org/02htbg024","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118300"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel L. Adams","raw_affiliation_strings":["3Creatv Microtech Inc., Potomac, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Creatv Microtech Inc., Potomac, MD","institution_ids":["https://openalex.org/I4210118300"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085436504","display_name":"Kathleen Tenner","orcid":"https://orcid.org/0000-0003-4607-4286","observed_orcids":["https://orcid.org/0000-0003-4607-4286"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen S. Tenner","raw_affiliation_strings":["2Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021852926","display_name":"Cha\u2010Mei Tang","orcid":"https://orcid.org/0000-0003-3017-0732","observed_orcids":["https://orcid.org/0000-0003-3017-0732"]},"institutions":[{"id":"https://openalex.org/I4210118300","display_name":"Creatv MicroTech (United States)","ror":"https://ror.org/02htbg024","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118300"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cha-Mei Tang","raw_affiliation_strings":["3Creatv Microtech Inc., Potomac, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Creatv Microtech Inc., Potomac, MD","institution_ids":["https://openalex.org/I4210118300"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078223091","display_name":"Morgan T. Weidner","orcid":"https://orcid.org/0009-0003-0550-6940","observed_orcids":["https://orcid.org/0009-0003-0550-6940"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Morgan T. Weidner","raw_affiliation_strings":["1Mayo Clinic Florida, Jacksonville, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic Florida, Jacksonville, FL;","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086826216","display_name":"Amanda N. Arnold","orcid":"https://orcid.org/0009-0007-1555-1314","observed_orcids":["https://orcid.org/0009-0007-1555-1314"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda N. Arnold","raw_affiliation_strings":["1Mayo Clinic Florida, Jacksonville, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic Florida, Jacksonville, FL;","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061165370","display_name":"Dana L. Haley","orcid":"https://orcid.org/0009-0000-7800-2370","observed_orcids":["https://orcid.org/0009-0000-7800-2370"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dana L. Haley","raw_affiliation_strings":["1Mayo Clinic Florida, Jacksonville, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic Florida, Jacksonville, FL;","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012173490","display_name":"Pooja Prem Advani","orcid":"https://orcid.org/0009-0007-5470-3149","observed_orcids":["https://orcid.org/0009-0007-5470-3149"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pooja Advani","raw_affiliation_strings":["1Mayo Clinic Florida, Jacksonville, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic Florida, Jacksonville, FL;","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051516231","display_name":"Kostandinos Sideras","orcid":"https://orcid.org/0000-0002-4698-2105","observed_orcids":["https://orcid.org/0000-0002-4698-2105"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kostandinos Sideras","raw_affiliation_strings":["1Mayo Clinic Florida, Jacksonville, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic Florida, Jacksonville, FL;","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027821205","display_name":"Alvaro Moreno\u2010Aspitia","orcid":"https://orcid.org/0000-0002-2317-2580","observed_orcids":["https://orcid.org/0000-0002-2317-2580"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alvaro Moreno-aspitia","raw_affiliation_strings":["1Mayo Clinic Florida, Jacksonville, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic Florida, Jacksonville, FL;","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065306642","display_name":"Edith A. Perez","orcid":"https://orcid.org/0000-0002-5037-6677","observed_orcids":["https://orcid.org/0000-0002-5037-6677","https://orcid.org/0000-0001-7009-7467"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edith A. Perez","raw_affiliation_strings":["1Mayo Clinic Florida, Jacksonville, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic Florida, Jacksonville, FL;","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031005364","display_name":"Keith L. Knutson","orcid":"https://orcid.org/0000-0001-9932-4467","observed_orcids":["https://orcid.org/0000-0001-9932-4467"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith L. Knutson","raw_affiliation_strings":["1Mayo Clinic Florida, Jacksonville, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mayo Clinic Florida, Jacksonville, FL;","institution_ids":["https://openalex.org/I4210146710"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"5454","last_page":"5454"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8330000042915344,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8330000042915344,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.1429000049829483,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.00989999994635582,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9760000109672546},{"id":"https://openalex.org/keywords/binimetinib","display_name":"binimetinib","score":1.0},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9739999771118164},{"id":"https://openalex.org/keywords/ras-mapk-pathway","display_name":"RAS/MAPK pathway","score":0.9079999923706055},{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.6790000200271606},{"id":"https://openalex.org/keywords/cancer-associated-macrophage-like-cells","display_name":"cancer-associated macrophage-like cells","score":0.8820000290870667},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.8240000009536743},{"id":"https://openalex.org/keywords/p-erk","display_name":"p-ERK","score":0.8330000042915344},{"id":"https://openalex.org/keywords/peripheral-blood-biomarkers","display_name":"peripheral blood biomarkers","score":0.8650000095367432},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7900000214576721},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6610000133514404},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9629999995231628},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6669999957084656},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.6129999756813049},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.7990000247955322},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8366756439208984},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8346261978149414},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5720869302749634},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.5369930267333984},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4952673017978668},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4932035803794861},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.48926374316215515},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.46292778849601746},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43598923087120056},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4272405803203583},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3092842400074005},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.1838897168636322}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-5454","doi":"https://doi.org/10.1158/1538-7445.am2023-5454","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-5454","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4396587512","https://openalex.org/W4322760455","https://openalex.org/W3005022366","https://openalex.org/W4408212925","https://openalex.org/W3179751602","https://openalex.org/W2791885889","https://openalex.org/W4414085154","https://openalex.org/W4393988957","https://openalex.org/W4411286175","https://openalex.org/W4365512273"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Activation":[2],"of":[3,26,57,147,156,168,451,497,518],"the":[4,24,184,385,449,519],"RAS/MAPK":[5],"pathway":[6],"is":[7],"associated":[8,310,351,376,426],"with":[9,45,52,66,77,128,152,174,195,205,223,275,311,352,377,400,427,501,506],"reduced":[10],"tumor-infiltrating":[11],"lymphocytes":[12],"and":[13,28,85,100,114,125,130,136,181,208,228,259,285,298,330,342,369,393,421,531],"poor":[14],"outcomes":[15],"in":[16,37,97,107,165,171,188,247,271,294,300,326,332,346,360,371,380,387,407,417,493,499,504],"triple-negative":[17,512],"breast":[18,513],"cancer":[19],"(TNBC).":[20],"This":[21],"trial":[22],"evaluated":[23,34],"efficacy":[25,450],"pembrolizumab":[27,498],"MEK":[29],"inhibitor,":[30],"binimetinib.":[31],"Here":[32],"we":[33],"potential":[35,431],"biomarkers":[36,433,492],"peripheral":[38],"blood":[39,491],"to":[40,434,437,446],"predict":[41,435],"response.":[42,212],"Methods:":[43],"Patients":[44],"unresectable":[46,507],"locally":[47,508],"advanced":[48,509],"or":[49,510],"metastatic":[50,511],"TNBC":[51],"\u2264":[53],"3":[54,176,197],"prior":[55],"lines":[56],"therapy":[58],"were":[59,72,120,140,150,201,209,308,348,375,424],"enrolled.":[60],"Treatment":[61],"includes":[62],"a":[63,153,358],"2-week":[64],"run-in":[65],"binimetinib":[67,78,394,503],"followed":[68],"by":[69],"pembrolizumab.":[70],"There":[71,200,266],"2":[73,166],"dose":[74],"levels":[75],"(DL)":[76],"at":[79,82,88,395],"45":[80],"mg":[81,87,397],"DL":[83,89,172,189,206],"0":[84],"30":[86,396],"-1.":[90],"A":[91,145],"standard":[92],"3+3":[93],"design":[94,104],"was":[95,105,163,192,218,241,252,261,267,282,288,405],"used":[96,106,141],"phase":[98,108],"I,":[99],"Simon\u2019s":[101],"two-stage":[102],"Optimal":[103],"II.":[109],"Circulating":[110],"tumor":[111],"cells":[112,118],"(CTC)":[113],"circulating":[115],"cancer-associated":[116],"macrophage-like":[117],"(CAML)":[119],"isolated":[121],"using":[122],"CellSieve":[123],"microfilters":[124],"immunofluorescently":[126],"labeled":[127],"PD-L1":[129,293,343,370,413,422],"p-ERK.":[131],"Wilcoxon":[132],"rank":[133],"sum":[134],"test":[135],"Cox":[137,355],"regression":[138,356],"model":[139],"for":[142,211,522],"analysis.":[143],"Results:":[144],"total":[146],"22":[148],"patients":[149,170,187,203,248,274,408,505],"enrolled,":[151],"median":[154],"age":[155],"58":[157],"years":[158],"old.":[159],"Dose-limiting":[160],"toxicity":[161],"(DLT)":[162],"observed":[164,270,406],"out":[167],"4":[169,229],"0,":[173],"grade":[175,196],"ALT":[177],"abnormality,":[178],"flank":[179],"pain,":[180],"nausea.":[182],"In":[183],"next":[185],"6":[186],"-1,":[190],"there":[191],"1":[193,224,306,529],"DLT":[194],"AST/ALT":[198],"abnormality.":[199],"17":[202],"treated":[204],"-1":[207],"evaluable":[210],"The":[213,233],"objective":[214],"response":[215,226,269,436],"rate":[216,236],"(ORR)":[217],"29.41%":[219],"(95%":[220,243,254,263],"CI:":[221,244,255,264],"10.31-55.9)":[222],"complete":[225],"(CR)":[227],"partial":[230],"responses":[231],"(PR).":[232],"clinical":[234,442],"benefit":[235],"(CBR":[237],"\u2265":[238],"24":[239],"weeks)":[240],"35.29%":[242],"14.21-61.67).":[245],"ORR":[246],"without":[249,409],"liver":[250,276,410],"metastases":[251],"55.56%":[253],"21.20":[256],"-":[257],"86.30),":[258],"CBR":[260],"66.67%":[262],"29.93-92.51).":[265],"no":[268],"all":[272],"5":[273],"metastases.":[277,411],"Baseline":[278,292,412],"mean":[279],"CTC":[280,315,333],"count":[281,287,318,336,362],"1.3":[283],"cells,":[284],"CAML":[286,295,301,317,321,327,335,347,361,365,372,418],"8.9":[289],"cells/7.5":[290],"mL.":[291],"(p":[296,303,319,323,328,337,340,344,363,367,373,389],"0.04)":[297],"decline":[299],"size":[302,322,366],"0.02)":[304],"after":[305],"cycle":[307],"significantly":[309,350,425],"CBR.":[312],"However,":[313],"baseline":[314],"count,":[316,334,419],"0.64),":[320],"0.46),":[324],"p-ERK":[325,339,388],"0.23),":[329],"changes":[331],"0.83),":[338],"0.07),":[341],"0.08)":[345],"not":[349,384],"responses.":[353],"Using":[354],"analysis,":[357],"reduction":[359,386,416],"0.02),":[364],"0.01),":[368],"0.03)":[374],"significant":[378],"improvement":[379],"overall":[381],"survival":[382],"but":[383],"0.6).":[390],"Conclusions:":[391],"Pembrolizumab":[392],"are":[398,444],"safe":[399],"manageable":[401],"toxicities.":[402],"Promising":[403],"activity":[404],"expression,":[414],"early":[415],"size,":[420],"expression":[423],"subsequent":[428],"responses,":[429],"providing":[430],"noninvasive":[432],"this":[438,452],"combination.":[439,453],"Future":[440],"larger":[441],"trials":[443],"warranted":[445],"further":[447],"evaluate":[448],"Citation":[454],"Format:":[455],"Saranya":[456],"Chumsri,":[457],"Joseph":[458],"J.":[459],"Larson,":[460],"Daniel":[461],"L.":[462,476,488],"Adams,":[463],"Kathleen":[464],"S.":[465],"Tenner,":[466],"Cha-Mei":[467],"Tang,":[468],"Morgan":[469],"T.":[470],"Weidner,":[471],"Amanda":[472],"N.":[473],"Arnold,":[474],"Dana":[475],"Haley,":[477],"Pooja":[478],"Advani,":[479],"Kostandinos":[480],"Sideras,":[481],"Alvaro":[482],"Moreno-aspitia,":[483],"Edith":[484],"A.":[485],"Perez,":[486],"Keith":[487],"Knutson.":[489],"Peripheral":[490],"Phase":[494],"II":[495],"study":[496],"combination":[500],"oral":[502],"cancer.":[514],"[abstract].":[515],"In:":[516],"Proceedings":[517],"American":[520],"Association":[521],"Cancer":[523,542],"Research":[524],"Annual":[525],"Meeting":[526],"2023;":[527],"Part":[528],"(Regular":[530],"Invited":[532],"Abstracts);":[533],"2023":[534],"Apr":[535],"14-19;":[536],"Orlando,":[537],"FL.":[538],"Philadelphia":[539],"(PA):":[540],"AACR;":[541],"Res":[543],"2023;83(7_Suppl):Abstract":[544],"nr":[545],"5454.":[546]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-06-10T00:00:00"}